OverviewSuggest Edit
Endologix, Inc. is singularly focused on providing innovative, minimally invasive technologies for aortic disorders. The Company's product offering includes a variety of endovascular stent grafts for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture. Designed around key issues with challenging anatomies, difficult access, and aneurysm sealing, Endologix products have been clinically proven in delivering positive patient outcomes.
| Type | Public | |
| Founded | 1992 | |
| HQ | Irvine, US | Map |
| Website | endologix.com | |
| Employee Ratings | More |
Key People/Management at Endologix
John Onopchenko
Vaseem Mahboob
Michael Chobotov
Matthew Thompson
Meg Carr
Joseph A. DeJohn
Endologix Office Locations
Endologix Financials and Metrics
Endologix Revenue
| USD | |
|---|---|
Revenue (Q2, 2019) | 36.2m |
Gross profit (Q2, 2019) | 23.0m |
Gross profit margin (Q2, 2019), % | 63.4% |
Net income (Q2, 2019) | (27.1m) |
EBIT (Q2, 2019) | (9.9m) |
Market capitalization (11-Oct-2019) | 64.4m |
Closing stock price (11-Oct-2019) | 3.7 |
Cash (30-Jun-2019) | 50.9m |
| USD | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 |
|---|---|---|---|---|---|---|---|---|
Net Income | (21.3m) | (37.6m) | (51.9m) | (19.8m) | (43.6m) | (53.8m) | (22.0m) | (49.2m) |
Depreciation and Amortization | 2.3m | 4.6m | 6.9m | 2.0m | 3.9m | 5.9m | 1.7m | 3.5m |
Inventories | (1.5m) | (2.2m) | (1.0m) | (784.0k) | 1.8m | 2.1m | 112.0k | (463.0k) |
Accounts Payable | (4.5m) | (3.5m) | (3.4m) | 391.0k | 809.0k | (1.0m) | 5.4m | 1.7m |
| USD | Y, 2019 |
|---|---|
Financial Leverage | 4.5 x |
Endologix Online and Social Media Presence
468 Twitter followers
Endologix has 468 Twitter Followers. The number of followers has increased 1.3% month over month and increased 4.8% quarter over quarter
Endologix's Trends
Twitter Engagement Stats for @endologix
253
Tweets
250
Following
468
Followers
1
Tweets last 30 days
2
Avg. likes per Tweet
100%
Tweets with engagement
Endologix News and Updates
Endologix Blogs
Endologix Announces Equity Financing of $52 Million and Debt Restructuring Addressing 2020 Maturities and Financial Covenants
Endologix Takes Decisive Action to Optimize Patient Outcomes by Ensuring Nellix System Used Only within Current Indications
Endologix Honors Innovators of Aortic Therapy at VEITHsymposium
FDA Classifies Previous Endologix AFX Safety Notice as Class I Recall
Endologix Announces Third Quarter Preliminary Revenue Results and Raises Low End of 2018 Revenue Guidance Range
Endologix Appoints Jeffrey S. Brown as Chief Operations Officer
Endologix Frequently Asked Questions
When was Endologix founded?
Endologix was founded in 1992.
Who are Endologix key executives?
Endologix's key executives are John Onopchenko, Vaseem Mahboob and Michael Chobotov.
How many employees does Endologix have?
Endologix has 528 employees.
What is Endologix revenue?
Latest Endologix annual revenue is $156.5 m.
What is Endologix revenue per employee?
Latest Endologix revenue per employee is $296.4 k.
Who are Endologix competitors?
Competitors of Endologix include U.S. Stem Cell, Cannabis Sativa and Vital Therapies.
Where is Endologix headquarters?
Endologix headquarters is located at 2 Musick, Irvine.
Where are Endologix offices?
Endologix has offices in Irvine and Rosmalen.
How many offices does Endologix have?
Endologix has 2 offices.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies